Constantinos Demopoulos

Prof. Constantinos Demopoulos

National and Kapodistrian University of Athens
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2003 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
CDConstantinos Demopoulos
Constantinos Demopoulos
HKHaralabos C. Karantonis
Haralabos C. Karantonis
SASmaragdi Antonopoulou
Smaragdi Antonopoulou

3 December 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Ronan LordanRonan Lordan
Ronan Lordan
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
Ioannis ZabetakisIoannis Zabetakis
Ioannis Zabetakis
CDConstantinos Demopoulos
Constantinos Demopoulos
In the late 1960s, Barbaro and Zvaifler described a substance that caused antigen induced histamine release from rabbit platelets producing antibodies in passive cutaneous anaphylaxis. Henson described a ‘soluble factor’ released from leukocytes that induced vasoactive amine release in platelets. Later observations by Siraganuan and Osler observed the existence of a diluted substance that had the capacity to cause platelet activation. In 1972, the term platelet-activating factor (PAF) was coined by Benveniste, Henson, and Cochrane. The structure of PAF was later elucidated by Demopoulos, Pinckard, and Hanahan in 1979. These studies introduced the research world to PAF, which is now recognised as a potent phospholipid mediator. Since its introduction to the literature, research on PAF has grown due to interest in its vital cell signalling functions and more sinisterly its role as a pro-inflammatory molecule in several chronic diseases including cardiovascular disease and cancer. As it is forty years since the structural elucidation of PAF, the aim of this review is to provide a historical account of the discovery of PAF and to provide a general overview of current and future perspectives on PAF research in physiology and pathophysiology.

31 January 2002 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Haralabos Christos KarantonisHaralabos Christos Karantonis
Haralabos Christos Karantonis
SASmaragdi Antonopoulou
Smaragdi Antonopoulou
CDConstantinos Demopoulos
Constantinos Demopoulos

30 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Paraskevi DetopoulouParaskevi Detopoulou
Paraskevi Detopoulou
CDConstantinos Demopoulos
Constantinos Demopoulos
SASmaragdi Antonopoulou
Smaragdi Antonopoulou
The new coronavirus disease 2019 (COVID-19) pandemic is an emerging situation with high rates of morbidity and mortality, in the pathophysiology of which inflammation and thrombosis are implicated. The disease is directly connected to the nutritional status of patients and a well-balanced diet is recommended by official sources. Recently, the role of platelet activating factor (PAF) was suggested in the pathogenesis of COVID-19. In the present review several micronutrients (vitamin A, vitamin C, vitamin E, vitamin D, selenium, omega-3 fatty acids, and minerals), phytochemicals and Mediterranean diet compounds with potential anti-COVID activity are presented. We further underline that the well-known anti-inflammatory and anti-thrombotic actions of the investigated nutrients and/or holistic dietary schemes, such as the Mediterranean diet, are also mediated through PAF. In conclusion, there is no single food to prevent coronavirus Although the relationship between PAF and COVID-19 is not robust, a healthy diet containing PAF inhibitors may target both inflammation and thrombosis and prevent the deleterious effects of COVID-19. The next step is the experimental confirmation or not of the PAF-COVID-19 hypothesis.

1 January 2007 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
EFElizabeth Fragopoulou
Elizabeth Fragopoulou
TNTzortzis Nomikos
Tzortzis Nomikos
CIChristos Iatrou
Christos Iatrou
SASmaragdi Antonopoulou
Smaragdi Antonopoulou
CDConstantinos Demopoulos
Constantinos Demopoulos
Platelet activating factor (PAF), a potent inflammatory mediator, is implicated in several proinflammatory/inflammatory diseases such as glomerulonephritis, glomerulosclerosis, atherosclerosis, cancer, allergy, and diabetes. PAF can be produced by several renal cells under appropriate stimuli and it is thought to be implicated in renal diseases. The aim of this study is the characterization of DTT-insensitive cholinephosphotransferase (PAF-CPT) of human mesangial cell (HMC), the main regulatory enzyme of PAFde novobiosynthetic pathway. Microsomal fractions of mesangial cells were isolated and enzymatic activity and kinetic parameters were determined by TLC and in vitro biological test in rabbit washed platelets. The effect of bovine serum albumin (BSA), dithiothreitol (DTT), divalent cations (Mg2+and Ca2+), EDTA, and various chemicals on the activity of PAF-CPT of HMC was also studied. Moreover, preliminary in vitro tests have been performed with several anti-inflammatory factors such as drugs (simvastatin, IFNa, rupatadine, tinzaparin, and salicylic acid) and bioactive compounds of Mediterranean diet (resveratrol and lipids of olive oil, olive pomace, sea bass “Dicentrarchuslabrax,” and gilthead sea bream “Sparus aurata”). The results indicated that the above compounds can influence PAF-CPT activity of HMC.

1 August 2008 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
Haralabos Christos KarantonisHaralabos Christos Karantonis
Haralabos Christos Karantonis
NTNektaria Tsantila
Nektaria Tsantila
GSGeorge Stamatakis
George Stamatakis
MSMartina Samiotaki
Martina Samiotaki
GPGeorge Panayotou
George Panayotou
CDConstantinos Demopoulos
Constantinos Demopoulos